These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21299478)

  • 1. The COPD pipeline VIII.
    Gross NJ
    COPD; 2011 Feb; 8(1):52-4. PubMed ID: 21299478
    [No Abstract]   [Full Text] [Related]  

  • 2. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J; Hag H; Jungck D; Urban K; Koch A
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFC Phase-Out and the Chiesi Solution.
    Huchon G; Fabbri LM
    Respiration; 2005; 72 Suppl 1():1-2. PubMed ID: 15915005
    [No Abstract]   [Full Text] [Related]  

  • 4. The COPD pipeline VII.
    Gross NJ
    COPD; 2010 Dec; 7(6):438-40. PubMed ID: 21166632
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective phosphodiesterase 4 inhibition. Controlling inflammation--also in patients with COPD].
    MMW Fortschr Med; 2004 Apr; 146(18):59. PubMed ID: 15366479
    [No Abstract]   [Full Text] [Related]  

  • 6. Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol.
    DeCanio SJ; Norman CS
    J Environ Manage; 2007 Oct; 85(1):1-8. PubMed ID: 16982135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COPD Pipeline XIII.
    Gross NJ
    COPD; 2011 Dec; 8(6):464-5. PubMed ID: 22149408
    [No Abstract]   [Full Text] [Related]  

  • 8. The COPD Pipeline IX.
    Gross NJ
    COPD; 2011 Apr; 8(2):136-8. PubMed ID: 21495841
    [No Abstract]   [Full Text] [Related]  

  • 9. Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat Soft Mist inhaler: results of phase II single-dose crossover studies.
    Koehler D; Pavia D; Dewberry H; Hodder R
    Respiration; 2004; 71(5):469-76. PubMed ID: 15467324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics as immunomodulant agents in COPD.
    Blasi F; Mantero M; Aliberti S
    Curr Opin Pharmacol; 2012 Jun; 12(3):293-9. PubMed ID: 22321568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetomilast.
    O'Mahony S
    IDrugs; 2005 Jun; 8(6):502-7. PubMed ID: 15906198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The president speaks: prevention is best: lessons from protecting the ozone layer.
    Woodcock A
    Thorax; 2012 Dec; 67(12):1028-31. PubMed ID: 23019254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COPD pipeline IV.
    Gross NJ
    COPD; 2010 Jun; 7(3):229-31. PubMed ID: 20486822
    [No Abstract]   [Full Text] [Related]  

  • 14. COPD patients: take a deep breath.
    Johns Hopkins Med Lett Health After 50; 2008 Apr; 20(2):7. PubMed ID: 18705144
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel cosuspension metered-dose inhalers for the combination therapy of chronic obstructive pulmonary disease and asthma.
    Lechuga-Ballesteros D; Noga B; Vehring R; Cummings RH; Dwivedi SK
    Future Med Chem; 2011 Oct; 3(13):1703-18. PubMed ID: 21942257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The COPD Pipeline XVII.
    Gross N
    COPD; 2012 Aug; 9(4):432-4. PubMed ID: 22734623
    [No Abstract]   [Full Text] [Related]  

  • 18. Soft drugs for future treatment of chronic obstructive pulmonary disease (COPD).
    Szelenyi I
    Pharmazie; 2012 May; 67(5):371-3. PubMed ID: 22764565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel concepts in the pharmacotherapy of chronic obstructive pulmonary disease.
    Celli BR
    Pneumonol Alergol Pol; 2009; 77(1):82-90. PubMed ID: 19308915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.